Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-29

Clinical Trial Update: Misoprostol Before Elective Caesarean Section for Decreasing the Neonatal Respiratory Morbidity [NA]

View source ↗

Summary

This clinical trial examines giving misoprostol before elective cesarean delivery to reduce neonatal respiratory morbidity, including transient tachypnea of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Ain Shams University | Conditions: Transient Tachypnea Newborn, Cesarean Delivery Affecting Fetus | NA | Status: UNKNOWN